TGF-β: elusive target in diabetic kidney disease
Authors:
- Priya RaniPRPriya Rani
- Sindhura Lakshmi Koulmane LaxminarayanaSLSindhura Lakshmi Koulmane Laxminarayana
- Shilna Muttickal SwaminathanSSShilna Muttickal Swaminathan
- Shankar Prasad NagarajuSNShankar Prasad Nagaraju
- Mohan Varadanayakanahalli BhojarajaMBMohan Varadanayakanahalli Bhojaraja
- Sahana ShettySSSahana Shetty
- Sushma Thimmaiah KanakalakshmiSKSushma Thimmaiah Kanakalakshmi
Top Cited Papers
Open Access
- 3 April 2025
- journal article
- review article
- Published by Taylor & Francis in Renal Failure
- Vol. 47 (1) , 2483990
Abstract
Transforming growth factor-beta (TGF-β), a cytokine with near omnipresence, is an integral part of many vital cellular processes across the human body. The family includes three isoforms: Transforming growth factor-beta 1, 2, and 3. These cytokines play a significant role in the fibrosis cascade. Diabetic kidney disease (DKD), a major complication of diabetes, is increasing in prevalence daily, and the classical diagnosis of diabetes is based on the presence of albuminuria. The occurrence of nonalbuminuric DKD has provided new insight into the pathogenesis of this disease. The emphasis on multifactorial pathways involved in developing DKD has highlighted some markers associated with tissue fibrosis. In diabetic nephropathy, TGF-β is significantly involved in its pathology. Its presence in serum and urine means that it could be a diagnostic tool while its regulation provides potential therapeutic targets. Completely blocking TGF-β signaling could reach untargeted regions and cause unanticipated effects. This paper reviews the basic details of TGF-β as a cytokine, its role in DKD, and updates on research carried out to validate its candidacy.Keywords
This publication has 113 references indexed in Scilit:
- Structure, unique biological properties, and mechanisms of action of transforming growth factor βBioorganic Chemistry, 2024
- UBR7 in concert with EZH2 inhibits the TGF-β signaling leading to extracellular matrix remodelingCell Reports, 2024
- Research progress on the role of PDGF/PDGFR in type 2 diabetesBiomedicine & Pharmacotherapy, 2023
- Monocyte chemoattractant protein‐1 predicts the development of diabetic nephropathyDiabetes/Metabolism Research and Reviews, 2021
- TGF‐β signaling: A recap of SMAD‐independent and SMAD‐dependent pathwaysJournal of Cellular Physiology, 2021
- Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatmentBiomedicine & Pharmacotherapy, 2018
- Connective tissue growth factor induces renal fibrosis via epidermal growth factor receptor activationThe Journal of Pathology, 2017
- Serum and urinary transforming growth factor beta 1 as biochemical markers in diabetic nephropathy patientsBeni-Suef University Journal of Basic and Applied Sciences, 2014
- Integrin-mediated regulation of TGFβ in fibrosisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013
- Latent forms of TGF‐β: Molecular Structure and Mechanisms of Activation2007